Navigation Links
Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011
Date:6/9/2011

BLUE BELL, Pa., June 9, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its majority-owned subsidiary, VGX Animal Health, Inc, will present at VetHealth Global 2011, an international animal health and nutrition business conference being held June 14-17, 2011, in Charlottetown, Prince Edward Island, Canada.  Douglas Kern, DVM, VGX Animal Health's Vice President of Business Development, will make the presentation.

Dr. Kern will highlight VGX Animal Health's focus on companion animal products including their development of VAH-1000 for cancer-associated anemia in dogs and, VAH-1050C for chronic renal failure in cats and VAH-1050D for chronic renal failure in dogs. Dr. Kern will also discuss VGX Animal Health's recent work with VAH-5000D, a very promising "universal" DNA cancer vaccine candidate for use in dogs.

Dr. Kern will speak at the conference during:Session VInnovation Spotlight: Early Stage Company PresentationsPresentation:  VGX Animal Health, GHRH & TERT Programs; Overview and Investment PotentialThursday, June 16, 20118:30AM – 10AMDouglas Kern, DVM, Vice President of Business Development, VGX Animal HealthAbout VGX Animal Health

VGX Animal Health is developing DNA-based therapies for companion and food animals utilizing proprietary plasmid-based DNA delivery and expression technology to optimize an animal's natural biological and immunological potential. The company is a majority-owned subsidiary of Inovio Pharmaceuticals, Inc.

About Inovio Pharmaceuticals, Inc.

Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. Its SynCon™ vaccines are designed to provide broad cross-strain protection against
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011
2. Inovio Pharmaceuticals Market-Leading Intellectual Property Recognized by MDB Capital Award
3. Inovio Pharmaceuticals to Present at Investor Conferences
4. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
5. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
6. Inovio Pharmaceuticals to Present at Scientific Conferences
7. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
8. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
9. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
10. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
11. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  Regulatory affairs professionals ... where regulations are often strict and legislation is ... a demand for professionals who have a deep ... across a product lifecycle and demonstrate its use ... University of California, Irvine Extension , in partnership ...
(Date:8/31/2015)... 2015  Diplomat Pharmacy, Inc. (NYSE: DPLO ), the ... Hagerman , Chairman & CEO, and Sean Whelan , ... Mr. Hagerman and Mr. Whelan are scheduled to participate ... Boston on Wednesday, September 9, 2015 at 1:45 ... also scheduled to participate in the Robert W. Baird 2015 ...
(Date:8/31/2015)... Aug. 31, 2015  Qualcomm Incorporated (NASDAQ: ... Qualcomm Life, Inc., is collaborating with Davita ... management solutions powered by Qualcomm Life,s 2net™ Device ... enable continuous care, informed interventions and better management ... Qualcomm Life,s annual Connect 2015 ecosystem ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Diplomat to Participate in Upcoming Investor Conferences 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 2011 First Quarter Total Revenue $565 million, including $36 million ... growth for the combined company, excluding the impact of foreign exchange ... Diastat and Efudex, pro forma organic growth for the combined company ... EPS $0.02; Cash EPS $0.62 Excluding impact from ...
... 9, 2011 Medison and Samsung Electronics jointly announced ... company, a joint partnership between Korea,s leading diagnostic ultrasound ... most technologically-advanced electronics and consumer goods companies, has outlined ... leader in medical device industry. Mr. ...
Cached Medicine Technology:Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 2Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 3Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 4Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 5Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 6Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 7Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 8Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 9Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 10Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 11Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 12Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 13Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 14Samsung Medison Pledges to Become a World-Class Medical Device Company 2
(Date:8/31/2015)... Lisle, IL (PRWEB) , ... August 31, 2015 , ... ... announce that Firm Partner William Scott has been nominated by his peers to earn ... by less than five percent of attorneys in the state of Illinois. The nomination ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Vice President, Marketing and Corporate Communications. In this capacity, Michael will provide strategic ... is an industry leader in consumer-focused programs that have contributed to the company’s ...
(Date:8/31/2015)... Newton, North Carolina (PRWEB) , ... August 31, 2015 , ... ... Abernethy Laurels on Tuesday, September 1. , “Alive Inside” shadows a social ... nonprofit “MUSIC & MEMORY?.” , “It’s a documentary about bringing music to residents in ...
(Date:8/31/2015)... ... August 31, 2015 , ... David L. ... was one of the first doctors in the area to perform minimally invasive ... have been impressive: faster recovery, decreased immediate and long-term pain, and an accelerated ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... With the FCPX LUT Soft pack from ... LUT is a Lookup Table that contains a mathematical formula for modifying an image. The ... comes with 60 soft CUBE LUT files. , FCPX LUT Soft requires Final Cut ...
Breaking Medicine News(10 mins):Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2
... Leading patient safety software company to team up ... CAMBRIDGE, MA, Aug. 19 /PRNewswire/ - rL Solutions, the leading ... it will become the founding Corporate Alliance Sponsor of the ... Association. , As part of the partnership, rL Solutions will ...
... , SOMERSET, N.J., Aug. 19 The Tic ... Care (R), it will try to break the Guinness World Record(TM) in ... for charity. Cancer C are is a national nonprofit ... , , Starting today at 11 a.m. ET, individuals ...
... ... a successful strategic workforce planning process,” stated Jim Sirbasku, co-founder and CEO of Profiles ... provides guidelines for implementing each of those 6 components.” , ... Waco, TX (PRWEB) August 19, 2009 -- ...
... ... LLP is urging the manufacturers of the fentanyl or Duragesic pain patches ... potentially fatal overdose. Because of its high potency, patients who receive too much ... a fentanyl overdose. Watson Pharmaceuticals recalled one lot of its fentanyl patches on ...
... ... a group of dentists emphasizing the urgent need for dentists to screen patients for snoring ... , ... Dr. Laurence Barsh recently spoke at the first annual Somnomed Symposium in Oahu, HI to ...
... allows physicians to evaluate suspicious lesions using a variety ... information can help significantly in distinguishing benign from malignant ... published in the September issue of the American ... the study, performed at the University of Washington Medical ...
Cached Medicine News:Health News:rL Solutions to Become the Founding Corporate Alliance Sponsor of the Society for Healthcare Consumer Advocacy 2Health News:CancerCare(R) and the Tic Tac(R) Brand Attempt To Set a World Record in Times Square 2Health News:CancerCare(R) and the Tic Tac(R) Brand Attempt To Set a World Record in Times Square 3Health News:Profiles International Releases New Study Identifying Key Factors for Strategic Workforce Planning 2Health News:Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose 2Health News:Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose 3Health News:Laurence Barsh, DMD, Founder of Snoring Isn't Sexy, LLC Emphasizes Need to Evaluate and Treat Sleep Patients 2
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
ZyDoc offers a full medical transcription and documentation solution....
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: